{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Chase BA"],"funding":["Agency for Healthcare Research and Quality","AHRQ HHS"],"pagination":["536"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11765864"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(2)"],"pubmed_abstract":["<b>Background/Objectives</b>: Migraine is a common neurological disorder with highly variable characteristics. While genome-wide association studies have identified genetic risk factors that implicate underlying pathways, the influence of genetic susceptibility on disease characteristics or treatment response is incompletely understood. We examined the relationships between a previously developed standardized integrative migraine polygenic genetic risk score (PRS) and migraine characteristics in a real-world, treated patient cohort. <b>Methods</b>: This retrospective cohort study used covariate-adjusted regression to comprehensively evaluate associations between the PRS and clinical characteristics in 1653 treated migraine cases with European ancestry at baseline and, in 800 cases, after o"],"journal":["Journal of clinical medicine"],"pubmed_title":["Migraine Genetic Susceptibility Does Not Strongly Influence Migraine Characteristics and Outcomes in a Treated, Real-World, Community Cohort."],"pmcid":["PMC11765864"],"funding_grant_id":["R01HS024057","R01 HS024057"],"pubmed_authors":["Maraganore D","Zheng SL","Epshteyn A","Freedom T","Rubin S","Sanders AR","Chase BA","Xu J","Pham A","Dafer R","Frigerio R","Meyers S","Markopoulou K","Marcus R","Wei J","Mulford AJ","Semenov I","Mark A"],"additional_accession":[]},"is_claimable":false,"name":"Migraine Genetic Susceptibility Does Not Strongly Influence Migraine Characteristics and Outcomes in a Treated, Real-World, Community Cohort.","description":"<b>Background/Objectives</b>: Migraine is a common neurological disorder with highly variable characteristics. While genome-wide association studies have identified genetic risk factors that implicate underlying pathways, the influence of genetic susceptibility on disease characteristics or treatment response is incompletely understood. We examined the relationships between a previously developed standardized integrative migraine polygenic genetic risk score (PRS) and migraine characteristics in a real-world, treated patient cohort. <b>Methods</b>: This retrospective cohort study used covariate-adjusted regression to comprehensively evaluate associations between the PRS and clinical characteristics in 1653 treated migraine cases with European ancestry at baseline and, in 800 cases, after o","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-19T18:20:38.479Z","creation":"2025-04-19T18:20:38.479Z"},"accession":"S-EPMC11765864","cross_references":{"pubmed":["39860542"],"doi":["10.3390/jcm14020536"]}}